Journal rankings · indicator year 2009
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2009
Endocrinology, Diabetes and Metabolism journal rankings 2009
95 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 95 ranked journals in 2009. The median journal has an OJR of 0.93, below the world average of 1.00, up 0.02 on 2008; Q1 starts at OJR 1.50. The top three are Endocrine Reviews, Diabetes Care, and Best Practice & Research Clinical Endocrinology & Metabolism.
Ranks and citation indicators: 2009. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2006–2008, the window the 2009 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery500
- Pulmonary and Respiratory Medicine212
- Cardiology and Cardiovascular Medicine184
- Public Health, Environmental and Occupational Health180
- Oncology134
- Epidemiology119
- Infectious Diseases110
- Psychiatry and Mental health100
- Radiology, Nuclear Medicine and Imaging99
- Endocrinology, Diabetes and Metabolism95
- Physiology91
- Neurology87
Show all 42 subfields
- Pediatrics, Perinatology and Child Health64
- Orthopedics and Sports Medicine63
- Ophthalmology59
- Hematology55
- Dermatology51
- Obstetrics and Gynecology44
- Rheumatology39
- Nephrology37
- Pharmacology34
- Complementary and alternative medicine31
- Reproductive Medicine31
- Emergency Medicine30
- Geriatrics and Gerontology25
- Otorhinolaryngology21
- Pathology and Forensic Medicine18
- Rehabilitation18
- Immunology and Allergy16
- Critical Care and Intensive Care Medicine14
- Genetics11
- Hepatology10
- Anesthesiology and Pain Medicine9
- Urology9
- Gastroenterology7
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
95 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2008. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2006–2008, the window the 2009 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2006–2008 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2009. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 12.38Q1 | 30.10 9.36 up from 2008 | 100 | 76% | $3,750 | ||
2Diabetes CareAmerican Diabetes Association · United States | 3.33Q1 | 7.43 0.22 down from 2008 | 2,258 | 99% | — | ||
3Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 3.25Q1 | 6.44 0.79 down from 2008 | 163 | 6% | $4,450 | ||
4Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 3.21Q1 | 6.05 0.32 down from 2008 | 102 | 29% | $5,590 | ||
5The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 3.21Q1 | 7.32 0.61 down from 2008 | 2,389 | 56% | $3,750 | ||
6DiabetologiaSpringer Science+Business Media · Germany | 2.65Q1 | 6.31 0.59 down from 2008 | 1,078 | 89% | $3,490 | ||
7Journal of Internal MedicineWiley · United Kingdom | 2.50Q1 | 5.78 0.46 up from 2008 | 437 | 58% | $4,780 | ||
8Endocrine Related CancerBioscientifica · United Kingdom | 2.39Q1 | 4.91 1.71 down from 2008 | 313 | 87% | — | ||
9Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.13Q1 | 5.26 1.74 up from 2008 | 166 | 11% | $3,540 | ||
10Diabetes Obesity and MetabolismWiley · United Kingdom | 2.11Q1 | 4.89 0.05 down from 2008 | 406 | 22% | $5,380 | ||
11EndocrinologyOxford University Press · United States | 2.09Q1 | 4.79 0.34 down from 2008 | 2,109 | 63% | $3,750 | ||
12Journal of Diabetes ResearchOAHindawi Publishing Corporation · United Kingdom | 2.06Q1 | 3.57 0.93 down from 2008 | 46 | — | $2,760 | ||
13Clinical TherapeuticsElsevier BV · United States | 1.99Q1 | 4.00 0.01 up from 2008 | 722 | 8% | $4,240 | ||
14European Journal of EndocrinologyOxford University Press · United Kingdom | 1.97Q1 | 4.30 0.42 down from 2008 | 754 | 14% | $4,292 | ||
15Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom | 1.85Q1 | 3.69 0.61 up from 2008 | 144 | 21% | — | ||
16Cardiovascular DiabetologyOABioMed Central · United Kingdom | 1.76Q1 | 3.53 0.91 down from 2008 | 102 | 100% | $4,290 | ||
17Diabetes and Vascular Disease ResearchOASAGE Publishing · United Kingdom | 1.70Q1 | 4.03 1.22 up from 2008 | 142 | 44% | $2,100 | ||
18Pediatric DiabetesWiley · Denmark | 1.67Q1 | 3.93 0.52 up from 2008 | 288 | 48% | $2,740 | ||
19Diabetic MedicineWiley · United Kingdom | 1.65Q1 | 3.50 0.35 down from 2008 | 792 | 22% | $4,870 | ||
20Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 1.56Q1 | 4.07 0.62 up from 2008 | 231 | 20% | — | ||
21Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.54Q1 | 3.51 0.76 down from 2008 | 246 | 19% | $4,780 | ||
22Current Diabetes ReviewsBentham Science Publishers · Netherlands | 1.52Q1 | 3.37 1.66 up from 2008 | 111 | 6% | — | ||
23Diabetes & MetabolismElsevier BV · Netherlands | 1.51Q1 | 3.66 0.84 up from 2008 | 294 | 1% | $4,490 | ||
24Menopause The Journal of The North American Menopause SocietyLippincott Williams & Wilkins · United States | 1.50Q1 | 3.23 0.58 down from 2008 | 460 | 20% | — | ||
25Gender MedicineElsevier BV · United States | 1.48Q2 | 2.86 0.48 up from 2008 | 136 | 10% | — | ||
26Clinical EndocrinologyWiley · United Kingdom | 1.48Q2 | 3.20 0.24 down from 2008 | 1,058 | 31% | $4,250 | ||
27Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.46Q2 | 2.93 0.32 down from 2008 | 331 | 11% | $3,000 | ||
28Journal of EndocrinologyBioscientifica · United Kingdom | 1.41Q2 | 3.27 0.02 down from 2008 | 769 | 89% | — | ||
29Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.39Q2 | 3.13 0.02 up from 2008 | 115 | 100% | $2,990 | ||
30ThyroidMary Ann Liebert, Inc. · United States | 1.36Q2 | 2.87 0.34 down from 2008 | 634 | 17% | — | ||
31Endocrine Metabolic & Immune Disorders - Drug TargetsBentham Science Publishers · Netherlands | 1.27Q2 | 3.06 0.05 down from 2008 | 109 | 6% | — | ||
32Hormone Research in PaediatricsKarger Publishers · Switzerland | 1.17Q2 | 2.30 0.38 down from 2008 | 428 | 21% | — | ||
33Journal of Diabetes and its ComplicationsElsevier BV · United States | 1.14Q2 | 2.30 0.98 down from 2008 | 255 | 10% | $3,760 | ||
34Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 1.10Q2 | 2.55 0.03 down from 2008 | 937 | 9% | $4,410 | ||
35PeptidesElsevier BV · United States | 1.05Q2 | 2.97 0.32 up from 2008 | 1,008 | 21% | $3,710 | ||
36MaturitasElsevier BV · Netherlands | 1.05Q2 | 2.33 0.16 down from 2008 | 394 | 6% | $4,390 | ||
37ClimactericTaylor & Francis · United Kingdom | 1.05Q2 | 2.68 0.02 up from 2008 | 228 | 2% | — | ||
38The Aging MaleOAInforma · United Kingdom | 1.04Q2 | 2.52 0.96 down from 2008 | 65 | 83% | $2,557 | ||
39Menopause internationalSAGE Publishing · United Kingdom | 1.04Q2 | 1.83 1.50 up from 2008 | 47 | 9% | — | ||
40Growth Hormone & IGF ResearchElsevier BV · United Kingdom | 1.02Q2 | 2.58 0.24 up from 2008 | 208 | 19% | $3,570 | ||
41The Science of Diabetes Self-Management and CareSAGE Publishing · United States | 0.98Q2 | 2.55 0.03 down from 2008 | 240 | 20% | $4,400 | ||
42PituitarySpringer Science+Business Media · Netherlands | 0.98Q2 | 2.27 0.01 down from 2008 | 191 | 25% | $4,490 | ||
43Endocrine PathologySpringer Science+Business Media · United States | 0.98Q2 | 2.44 0.38 up from 2008 | 116 | 7% | $3,190 | ||
44EndocrineSpringer Science+Business Media · United States | 0.98Q2 | 1.82 0.52 down from 2008 | 286 | 16% | $3,090 | ||
45Endocrine PracticeElsevier BV · United States | 0.97Q2 | 1.78 0.65 down from 2008 | 507 | 8% | $3,480 | ||
46Current Diabetes ReportsSpringer Science+Business Media · United States | 0.97Q2 | 2.15 0.15 up from 2008 | 220 | 6% | $4,890 | ||
47Chronic IllnessSAGE Publishing · United Kingdom | 0.95Q2 | 2.07 0.98 up from 2008 | 94 | 6% | $4,150 | ||
48Endocrine JournalOAJapan Endocrine Society · Japan | 0.93Q2 | 2.27 0.24 up from 2008 | 406 | 99% | — | ||
49Hormone and Metabolic ResearchThieme Medical Publishers (Germany) · Germany | 0.93Q3 | 2.16 0.46 down from 2008 | 565 | 7% | — | ||
50Clinical Drug InvestigationAdis, Springer Healthcare · New Zealand | 0.91Q3 | 1.94 0.03 up from 2008 | 254 | 1% | $4,190 |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery500
- Pulmonary and Respiratory Medicine212
- Cardiology and Cardiovascular Medicine184
- Public Health, Environmental and Occupational Health180
- Oncology134
- Epidemiology119
- Infectious Diseases110
- Psychiatry and Mental health100
- Radiology, Nuclear Medicine and Imaging99
- Endocrinology, Diabetes and Metabolism95
- Physiology91
- Neurology87
- Pediatrics, Perinatology and Child Health64
- Orthopedics and Sports Medicine63
- Ophthalmology59
- Hematology55
- Dermatology51
- Obstetrics and Gynecology44
- Rheumatology39
- Nephrology37
- Pharmacology34
- Complementary and alternative medicine31
- Reproductive Medicine31
- Emergency Medicine30
- Geriatrics and Gerontology25
- Otorhinolaryngology21
- Pathology and Forensic Medicine18
- Rehabilitation18
- Immunology and Allergy16
- Critical Care and Intensive Care Medicine14
- Genetics11
- Hepatology10
- Anesthesiology and Pain Medicine9
- Urology9
- Gastroenterology7
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2009. Corpus-wide, 71.4% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
32 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2006–2008, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2009. Publication window: 2006–2008. How these summaries are calculated
- Ranked journals
- 95
- Window papers (baseline)
- 46,752 +42.8% from indicator year 2006
- Median OJR
- 0.93 +11.3% from indicator year 2006
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2006–2008 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.